首页> 外文期刊>Nanotoxicology >Comparative tissue distributions of cadmium chloride and cadmium-based quantum dot 705 in mice: Safety implications and applications
【24h】

Comparative tissue distributions of cadmium chloride and cadmium-based quantum dot 705 in mice: Safety implications and applications

机译:氯化镉和基于镉的量子点705在小鼠中的比较组织分布:安全隐患和应用

获取原文
获取原文并翻译 | 示例
           

摘要

Cadmium (Cd) is a component in quantum dot 705 (QD705). Whether QD705 behaves similar to Cd in vivo is of great concern. We compared the distributional kinetics of cadmium chloride (CdCl2) and QD705 in mice after intravenous injection. QD705 showed a longer plasma and body retention than CdCl2 and could be detected in the brain during early exposure. While both the liver and spleen demonstrated a constant Cd concentration for 28 days after QD705 injection, it is likely that this represents intact QD705 stored in mononuclear phagocytes. The kidneys showed a time-dependent accumulation of Cd in the QD705-exposed animals. By day 28, Cd in the kidneys from QD705 was 3-fold that of CdCl2. QD705 and CdCl2 have very different kinetics in distribution and metabolism. The long body retention of QD705 in the kidneys may mean that QD705 has even more renal toxicity than CdCl2.
机译:镉(Cd)是量子点705(QD705)中的成分。 QD705在体内的行为是否与Cd相似,是一个值得关注的问题。我们比较了静脉注射后氯化镉(CdCl2)和QD705在小鼠体内的分布动力学。 QD705具有比CdCl2更长的血浆和身体保留能力,可以在早期暴露期间在大脑中检测到。 QD705注射后28天,肝脏和脾脏均显示出恒定的Cd浓度,但这很可能代表完整的QD705储存在单核吞噬细胞中。肾脏在暴露于QD705的动物中显示出镉的时间依赖性积累。到第28天,来自QD705的肾脏中的Cd是CdCl2的3倍。 QD705和CdCl2在分布和新陈代谢方面具有非常不同的动力学。 QD705在肾脏中的长期体内滞留可能意味着QD705比CdCl2具有更大的肾脏毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号